# PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

> **NCT06902740** · PHASE4 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Intracranial Atherosclerosis
- Intracranial Artery Stenosis
- Atherosclerotic Plaque

## Interventions

- **DRUG:** Recaticimab and Statin
- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT06902740
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902740, "PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06902740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*